The Chinese University of Hong Kong — Hong Kong, Shatin

Public research footprint of The Chinese University of Hong Kong, compiled from the ClinicalTrials.gov public registry.

457

Registered studies

161

Active

Recruiting now

173

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Advanced or Unresectable Hepatocellular Carcinoma (HCC) · Post-Polycythemia Vera Myelofibrosis · NSCLC (Non-small Cell Lung Carcinoma)

Recently updated registry entries

NCT04656652 — Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small… (Active Not Recruiting)
NCT05702034 — A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk… (Active Not Recruiting)
NCT04419584 — Evaluate the Efficacy of Using Modified Qing-Ying Decoction in Atopic Dermatitis Children (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The Chinese University of Hong Kong?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.